BR Biopharma (NASDAQ:BRBI) Trading Up 0.5% – What’s Next?

BR Biopharma, Inc. (NASDAQ:BRBI) shares rose 0.5% during trading on Friday . The company traded as high as $9.40 and last traded at $9.40. Approximately 1,520 shares traded hands during mid-day trading, an increase of 287% from the average daily volume of 393 shares. The stock had previously closed at $9.35.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, BR Biopharma has a consensus rating of “Sell”.

BR Biopharma Stock Performance

The firm has a 50 day simple moving average of $11.32.

BR Biopharma (NASDAQ:BRBI) last announced its quarterly earnings data on Tuesday, June 30th. The company reported $0.09 EPS for the quarter. The firm had revenue of $25.13 million for the quarter.

BR Biopharma Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Monday, August 17th will be paid a $0.1415 dividend. This represents a $0.57 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date is Monday, August 17th.

Hedge Funds Weigh In On BR Biopharma

A hedge fund recently bought a new stake in BR Biopharma stock. Acuitas Investments LLC acquired a new stake in BR Biopharma, Inc. (NASDAQ:BRBI) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma makes up 3.2% of Acuitas Investments LLC’s portfolio, making the stock its 7th largest position.

BR Biopharma Company Profile

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.